Nobelpharma America
Manufacturing · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4520 East West Hwy Ste 400, Bethesda, Ma...Phone Number
(301) 244-5951Website
www.nobelpharma-us.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Nobelpharma America
Nobelpharma America is dedicated to developing critical but neglected pharmaceuticals and medical devices for diseases that are often overlooked by other companies. Established in 2003 in Tokyo, Japan, the company aims to contribute to medical care by manufacturing and delivering essential medicines. They collaborate with global experts to expedite the market introduction of First-In-Class and Best-In-Class drugs, particularly in the United States and Europe. Their mission focuses on providing much-needed treatments to patients and physicians, ensuring that even rare conditions receive attention.Explore more
Nobelpharma America Org Chart
RR
Southeast Region Key Account Manager
SM
Account Manager, Rare Disease Patient Access ...
JR
Rare Disease Key Account Manager (Dermatology...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nobelpharma America your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Nobelpharma America is spiking on competitors!
Nobelpharma America, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Nobelpharma America recently announced quarterly report
Funding: Get notified immidiatlly once Nobelpharma America has new funding data
Congratulate Masked Content for being promoted to Masked Content at Nobelpharma America
Click to see if Nobelpharma America had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Nobelpharma America has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Nobelpharma America launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Nobelpharma America
Compare insights from companies similar to Nobelpharma America, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nobelpharma America is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nobelpharma America is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nobelpharma America.
Nobelpharma America Tech Stack
A closer look at the technologies used by Nobelpharma America
See more technologies
Nobelpharma America News & Media
Rare Disease Treatment, HYFTOR® (sirolimus topical gel) 0.2% Coverage Expanded by Medicaid, Including in Key U.S. States
BETHESDA, Md., March 14, 2023 /PRNewswire/ -- HYFTOR® (sirolimus topical gel) 0.2%, indicated for the treatment of facial angiofibroma associated with tuberous sclerosis complex (TSC) in adults and pediatric patients 6 years of age and older, is now covered by Medicare in Texas, Florida,...HYFTOR™ (sirolimus topical gel) 0.2%, the first FDA-approved topical treatment for facial angiofibroma associated with tuberous sclerosis, is now available in the US
BETHESDA, Md., Aug. 30, 2022 /PRNewswire/ -- Nobelpharma America, LLC, a pharmaceutical and medical device company headquartered in Bethesda, Maryland, and a subsidiary of Nobelpharma Co., Ltd. in Tokyo, has initiated distribution of HYFTOR™ (sirolimus topical gel) 0.2% into the United...Nobelpharma America Debuts New Product, HYFTOR™ (sirolimus topical gel) 0.2%, at the 2022 World TSC Conference
– Nobelpharma Connect Patient Program to Be Introduced for the First Time – – Nobelpharma Is a Presenting Sponsor of the 2022 World TSC Conference – BETHESDA, Md., July 25, 2022 /PRNewswire/ -- Nobelpharma America, LLC, a pharmaceutical and medical device company headquartered in...Nobelpharma America Announces Presence at 75th American Epilepsy Society Annual Meeting
BETHESDA, Md., Nov. 29, 2021 /PRNewswire/ -- Nobelpharma America, LLC, a pharmaceutical and medical device company headquartered in Bethesda, Maryland, today announced its attendance at the American Epilepsy Society 2021 Annual Meeting, December 3-7, 2021. In addition to an exhibit booth,...
Read more news
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding Nobelpharma America
Sign Up For FreeTo access detailed company insights
Nobelpharma America is dedicated to developing critical but neglected pharmaceuticals and medical devices for diseases that are often overlooked by other companies. Established in 2003 in Tokyo, Japan, the company aims to contribute to medical care by manufacturing and delivering essential medicines. They collaborate with global experts to expedite... Read More
